The way we work is changing rapidly. The pandemic is causing us all to rethink how our teams work together. New tools for a new age are required to support remote work while, at the same time, improving our ability to collaborate regardless of where we are located. Climb 2.0 increases remote work flexibility, improves efficiency, and drives quality. This engaging slide and video tour developed by Chuck Donnelly and Julie Morrison takes you into the in vivo lab with short video snippets to show you how your digital transformation can improve lab efficiencies, improve quality, and speed time to discovery.
The term, Digital Transformation, describes a process in which an organization transforms from pencil and paper or basic digital tools like spreadsheets and stand-alone databases to become digitalized. A digitalized organization integrates appropriate data, logistics, and operations systems to create a seamless business management system built on digital information technologies and artificial intelligence. If done correctly, an organization that undergoes a digital transformation achieves double-digit operational efficiency improvements, reduces errors, and positions itself for scale. It is important to keep in mind that the transformation endpoint is not a fixed target; new technologies are continually integrated into the ecosystem. Thus, adopted architectures and technologies must be future-proof so that changing technologies can be introduced with minimal disruptions.
Digital transformations can create extreme winners
In vivo studies are complex, expensive, and must be conducted to exacting specifications. Oftentimes, procedures have dependencies and time constraints that require multiple technicians working hand in hand to get the work done. Many labs manage these timelines, tasks, and data collection with paper or spreadsheets. RockStep Solutions, working with Novartis, UCSF IND, and others, have developed a transformative database solution that digitalizes in vivo operations and data capture. RockStep’s President, Julie Morrison and Scientist.com‘s Category Director for In Vivo Services, Meaghan Loy, presented this webinar that focuses on the challenges of managing in vivo workflows.
RockStep Solutions and the Novartis in vivo study teams worked together for over year to design and develop software that is transforming how discovery workflows are conducted. The goal of the effort was to build the best in vivo software possible using “future proof” technologies and engineering practices. The project was lead by RockStep’s co-founder and President, Julie Morrison and members of the Novartis Head of Emerging Technologies working closely with the in vivo study team scientists, managers, and technicians. Julie Morrison, is also one of the Pistoia Alliance UXLS champions. The full article was published in Drug Discovery World.
In today’s competitive and highly regulated drug discovery industry, operational efficiency and compliancy are crucial to business success. This is especially true for the in vivo research phases where operational costs are high and security, compliance and safety can become significant concerns when data is poorly managed.